These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34768648)

  • 21. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
    Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА
    Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
    Cantini F; Goletti D; Petrone L; Najafi Fard S; Niccoli L; Foti R
    Drugs; 2020 Dec; 80(18):1929-1946. PubMed ID: 33068263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects.
    Al-Kuraishy HM; Al-Gareeb AI; Qusty N; Cruz-Martins N; El-Saber Batiha G
    Pulm Pharmacol Ther; 2021 Apr; 67():102008. PubMed ID: 33727066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colchicine in the management of Covid-19: With or lieu of evidence.
    Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Al-Gareeb AI
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S127-S132. PubMed ID: 35130235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection.
    AlNafea HM; Korish AA
    Blood Coagul Fibrinolysis; 2023 Apr; 34(3):129-137. PubMed ID: 36966750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 and Hypercoagulability: A Review.
    Kichloo A; Dettloff K; Aljadah M; Albosta M; Jamal S; Singh J; Wani F; Kumar A; Vallabhaneni S; Khan MZ
    Clin Appl Thromb Hemost; 2020; 26():1076029620962853. PubMed ID: 33074732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colchicine to reduce coronavirus disease-19-related inflammation and cardiovascular complications in high-risk patients post-acute infection with SARS-COV-2-a study protocol for a randomized controlled trial.
    Thankachen SS; Devasenapathy N; Bassi A; Ghosh A; Arfin S; Gummidi B; Basheer A; Bangi A; Sahu D; Bhalla A; Blesson M; Jain M; Jha V
    Trials; 2024 Jun; 25(1):378. PubMed ID: 38863076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between SARS-CoV-2 infections and thrombotic complications necessitating surgical intervention: A systematic review.
    Ferraro JJ; Reynolds A; Edoigiawerie S; Seu MY; Horen SR; Aminzada A; Hamidian Jahromi A
    World J Methodol; 2022 Nov; 12(6):476-487. PubMed ID: 36479312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.
    Rahhal A; Najim M; Aljundi AH; Mahfouz A; Alyafei SM; Awaisu A; Habib MB; Obeidat I; Faisal MM; Alanzi MA; Nair AP; Elhassan A; Al-Dushain A; Abdelmajid AA; Abdelgader AE; Moursi AMA; Alharafsheh AEN; Kamar MRA; Goravey W; Omar AS; Abukhattab M; Khatib MY; Mohamedali MG; AlMaslamani MAR; Alemadi S
    Medicine (Baltimore); 2022 Sep; 101(39):e30618. PubMed ID: 36181009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients.
    Montealegre-Gómez G; Garavito E; Gómez-López A; Rojas-Villarraga A; Parra-Medina R
    Reumatol Clin; 2021; 17(7):371-375. PubMed ID: 38620275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection.
    Boccatonda A; Campello E; Simion C; Simioni P
    Expert Rev Hematol; 2023; 16(12):1035-1048. PubMed ID: 38018136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Anticoagulation in COVID-19-Induced Hypercoagulability.
    Rico-Mesa JS; Rosas D; Ahmadian-Tehrani A; White A; Anderson AS; Chilton R
    Curr Cardiol Rep; 2020 Jun; 22(7):53. PubMed ID: 32556892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)].
    Mareev VY; Orlova YA; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Plisyk AG; Seredenina EM; Potapenko AV; Malakhov PS; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Asratyan DA; Zhdanova EA; Mareev YV; Begrambekova YL; Shatochina EA; Kamalov АА
    Kardiologiia; 2020 Oct; 60(9):4-21. PubMed ID: 33131470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients.
    Montealegre-Gómez G; Garavito E; Gómez-López A; Rojas-Villarraga A; Parra-Medina R
    Reumatol Clin (Engl Ed); 2021; 17(7):371-375. PubMed ID: 34301378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of colchicine in the management of COVID-19: a Meta-analysis.
    Elshiwy K; Amin GEE; Farres MN; Samir R; Allam MF
    BMC Pulm Med; 2024 Apr; 24(1):190. PubMed ID: 38641775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colchicine, Aspirin, and Montelukast - A Case of Successful Combined Pharmacotherapy for Adult Multisystem Inflammatory Syndrome in COVID-19.
    Downing S; Chauhan V; Chaudry IH; Galwankar S; Sharma P; Stawicki SP
    J Glob Infect Dis; 2020; 12(4):221-224. PubMed ID: 33888963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review.
    Louis TJ; Qasem A; Abdelli LS; Naser SA
    Microorganisms; 2022 Jan; 10(1):. PubMed ID: 35056603
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.